---
title: "Senti Biosciences, Inc. (SNTI.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/SNTI.US.md"
symbol: "SNTI.US"
name: "Senti Biosciences, Inc."
industry: "Biotechnology"
---

# Senti Biosciences, Inc. (SNTI.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.sentibio.com](https://www.sentibio.com) |

## Company Profile

Senti Biosciences, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. Its lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cell...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.44 | 135/605 | - | - | - |
| PB | 2.69 | 214/605 | 3.59 | 2.19 | 1.48 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-12-15T05:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 3 | 75% |
| Overweight | 1 | 25% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.83 |
| Highest Target | 15.00 |
| Lowest Target | 6.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/SNTI.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/SNTI.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/SNTI.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.